Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet

Endocrinology

Volumn 146, Issue 2, 2005, Pages 920-930

  Olsson, Bob ^a,b   Bohlooly Y, Mohammad ^a,b   Fitzgerald, Sharyn M ^a   Frick, Fredrik ^a,e   Ljungberg, Anna ^a,c   Ahrén, Bo ^d   Törnell, Jan ^a,b,e   Bergström, Göran ^a   Oscarsson, Jan ^a,c,e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; GROWTH HORMONE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2;

ACROMEGALY; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY MASS; BODY TEMPERATURE; CALORIC INTAKE; CALORIMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENERGY EXPENDITURE; GLUCOSE OXIDATION; HYPERPHAGIA; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ACROMEGALY; ANIMALS; BODY COMPOSITION; BODY TEMPERATURE; CARRIER PROTEINS; CATTLE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; EATING; ENERGY METABOLISM; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HYPERLIPIDEMIAS; HYPERPHAGIA; ION CHANNELS; LIPIDS; LIPOPROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, TRANSGENIC; MITOCHONDRIAL PROTEINS; OBESITY; OXYGEN CONSUMPTION;

EID: 12344326642     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1232     Document Type: Article

References (51)

1. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM 1982 Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300:611-615
2. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, Palmiter RD 1989 Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124:40-48
3. Frick F, Bohlooly YM, Lindén D, Olsson B, Törnell J, Edén S, Oscarsson J 2001 Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am J Physiol Endocrinol Metab 281:E1230-E1239
4. Eisen EJ, Peterson CB, Parker IJ, Murray JD 1998 Effects of zinc ion concentration on growth, fat content and reproduction in oMT1a-oGH transgenic mice. Growth Dev Aging 62:173-186
5. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK, Kopchick JJ 2004 Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res 14:309-318
6. Kopchick JJ, Bellush LL, Coschigano KT 1999 Transgenic models of growth hormone action. Annu Rev Nutr 19:437-461
7. Bengtsson BA, Brummer RJ, Edén S, Bosaeus I, Lindstedt G 1989 Body composition in acromegaly: the effect of treatment. Clin Endocrinol (Oxf) 31:481-490
8. Foss MC, Saad MJ, Paccola GM, Paula FJ, Piccinato CE, Moreira AC 1991 Peripheral glucose metabolism in acromegaly. J Clin Endocrinol Metab 72: 1048-1053
9. Nikkilä EA, Pelkonen R 1975 Serum lipids in acromegaly. Metabolism 24: 829-838
10. Oscarsson J, Wiklund O, Jakobsson KE, Petruson B, Bengtsson BA 1994 Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy. Clin Endocrinol (Oxf) 41:603-608
11. Bohlooly YM, Olsson B, Gritli-Linde A, Brusehed O, Isaksson OG, Ohlsson C, Söderpalm B, Törnell J 2001 Enhanced spontaneous locomotor activity in bovine GH transgenic mice involves peripheral mechanisms. Endocrinology 142:4560-4567
12. Blissett J, Harris G, Kirk J 2000 Effect of growth hormone therapy on feeding problems and food intake in children with growth disorders. Acta Paediatr 89:644-649
13. Azain MJ, Roberts TJ, Martin RJ, Kasser TR 1995 Comparison of daily versus continuous administration of somatotropin on growth rate, feed intake, and body composition in intact female rats. J Anim Sci 73:1019-1029
14. Clark RG, Jansson JO, Isaksson O, Robinson IC 1985 Intravenous growth hormone: growth responses to patterned infusions in hypophysectomized rats. J Endocrinol 104:53-61
15. Roberts TJ, Azain MJ, Hausman GJ, Martin RJ 1994 Interaction of insulin and somatotropin on body weight gain, feed intake, and body composition in rats. Am J Physiol 267:E293-E299
16. Schulz C, Wieczorek I, Reschke K, Lehnert H 2002 Effects of intracerebroventricularly and intraperitoneally administered growth hormone on body weight and food intake in fa/fa Zucker rats. Neuropsychobiology 45:36-40
17. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395
18. O'Sullivan AJ, Kelly JJ, Hoffman DM, Baxter RC, Ho KK 1995 Energy metabolism and substrate oxidation in acromegaly. J Clin Endocrinol Metab 80:486-491
19. Möller N, Schmitz O, Jörgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J 1992 Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74:1012-1019
20. Christiansen JJ, Vahl N, Fisker S, Möller N, Christiansen JS, Jörgensen JO 2002 Age dimorphism in the association between growth-hormone status and the respiratory quotient. Obes Res 10:284-290
21. Gerver WJ, De Bruin R, Delemarre v d Waal HA, Aldewereld B, Theunissen P, Westerterp KR 2000 Effects of discontinuation of growth hormone treatment on body composition and metabolism. Horm Res 53:215-220
22. Moura AS, Spiers DE, Lamberson WR 1998 Thermogenic activity of growth hormone transgenic mice. Growth Dev Aging 62:149-159
23. Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A 2001 Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Exp Biol Med Maywood 226:552-558
24. Yokode M, Hammer RE, Ishibashi S, Brown MS, Goldstein JL 1990 Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. Science 250:1273-1275
25. Masucci-Magoulas L, Goldberg IJ, Bisgaier CL, Serajuddin H, Francone OL, Breslow JL, Tall AR 1997 A mouse model with features of familial combined hyperlipidemia. Science 275:391-394
26. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN 1988 Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1167
27. Ahrén B, Scheurink AJ 1998 Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 139:461-467
28. Sandstedt J, Ohlsson C, Norjavaara E, Nilsson J, Törnell J 1994 Disproportional bone growth and reduced weight gain in gonadectomized male bovine growth hormone transgenic and normal mice. Endocrinology 135:2574-2580
29. Oscarsson J, Olofsson SO, Bondjers G, Edén S 1989 Differential effects of continuous versus intermittent administration of growth hormone to hypophysectomized female rats on serum lipoproteins and their apoproteins. Endocrinology 125:1638-1649
30. Brass ML, Black AL 1978 Enzymatic microdetermination of glycogen. Anal Biochem 84:309-312
31. Li X, Catalina F, Grundy SM, Patel S 1996 Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48-relative to B-100-containing lipoproteins. J Lipid Res 37:210-220
32. Ebara T, Ramakrishnan R, Steiner G, Shachter NS 1997 Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. J Clin Invest 99:2672-2681
33. Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, Thompson GR, Sönksen PH 1995 Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 38:959-967
34. Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Verges B 2000 Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Eur J Clin Invest 30:685-694
35. Schaefer GB, Greger NG, Fesmire JD, Blackett PR, Wilson DP, Frindik JP 1994 Lipids and apolipoproteins in growth hormone-deficient children during treatment. Metabolism 43:1457-1461
36. Grinspoon S, Mulligan K 2003 Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 36:S69-S78
37. Wolthers T, Groftne T, Möller N, Christiansen JS, Örskov H, Weeke J, Jörgensen JO 1996 Calorigenic effects of growth hormone: the role of thyroid hormones. J Clin Endocrinol Metab 81:1416-1419
38. Chen HL, Romsos DR 1995 A single intracerebroventricular injection of dexamethasone elevates food intake and plasma insulin and depresses metabolic rates in adrenalectomized obese (ob/ob) mice. J Nutr 125:540-545
39. Ravussin E, Bogardus C, Schwartz RS, Robbins DC, Wolfe RR, Horton ES, Danforth Jr E, Sims EA 1983 Thermic effect of infused glucose and insulin in man. Decreased response with increased insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Invest 72:893-902
40. Konarzewski M, Diamond J 1995 Evolution of basal metabolic rate and organ masses in laboratory mice. Evolution 49:1239-1248
41. Li Y, Knapp JR, Kopchick JJ 2003 Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice. Exp Biol Med Maywood 228:207-215
42. Enerbäck S, Jacobsson A, Simpson EM, Guerra C, Yamashita H, Harper ME, Kozak LP 1997 Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387:90-94
43. Jaburek M, Varecha M, Gimeno RE, Dembski M, Jezek P, Zhang M, Burn P, Tartaglia LA, Garlid KD 1999 Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J Biol Chem 274:26003-26007
44. Vidal-Puig A, Solanes G, Grujic D, Flier JS, Lowell BB 1997 UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 235:79-82
45. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH 1997 Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269-272
46. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W 2001 A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28:178-183
47. Le Fur S, Le Stunff C, Dos Santos C, Bougneres P 2004 The common -866 G/A polymorphism in the promoter of uncoupling protein 2 is associated with increased carbohydrate and decreased lipid oxidation in juvenile obesity. Diabetes 53:235-239
48. Olsson B, Bohlooly YM, Brusehed O, Isaksson OG, Ahrén B, Olofsson SO, Oscarsson J, Törnell J 2003 Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes. Am J Physiol Endocrinol Metab 285:E504-E511
49. Cortez-Pinto H, Zhi Lin H, Qi Yang S, Odwin Da Costa S, Diehl AM 1999 Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology 116:1184-1193
50. Tsuboyama-Kasaoka N, Takahashi M, Kim H, Ezaki O 1999 Up-regulation of liver uncoupling protein-2 mRNA by either fish oil feeding or fibrate administration in mice. Biochem Biophys Res Commun 257:879-885
51. Oscarsson J, Ottosson M, Vikman-Adolfsson K, Frick F, Enerbäck S, Lithell H, Eden S 1999 GH but not IGF-1 or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. J Endocrinol 160:247-255